From Start to Finish: How Agilent Can Support Better Decisions in IVT mRNA-Based Biopharmaceutical Analysis
Speakers: Whitney Pike, MA, Agilent Technologies, Dr. Sonja Schneider, Agilent Technologies, Olivia Long, SelectScienceWhitney Pike, MA, Agilent Technologies · Dr. Sonja Schneider, Agilent Technologies · Olivia Long, SelectScienceWhitney Pike, MA, Agilent TechnologiesDr. Sonja Schneider, Agilent TechnologiesOlivia Long, SelectScience · · +1 more · +2 more · +3 more
Watch on-demand